Infectious Complications Following HSCT

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Infectious Complications Following HSCT trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT04832607

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Haematopoietic stem cell transplantation (HSCT) can expose patients to a transient but marked immunosuppression, during which viral infections are an important…

Belgium, France +4 more149 participantsStarted 2019-08-27Updated 2025-07-18

Treatment: Multivirus (CMV, EBV, AdV)-specific T cells

All recent trials (13 shown)

Active — Not RecruitingPhase 2

NCT01295645

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

The goal of this clinical research study is to learn if adding cidofovir to the standard of care can improve symptoms of hemorrhagic cystitis caused by the BK v…

United States27 participantsStarted 2011-03-17Updated 2026-03-06

Treatment: Cidofovir, No Cidofovir

CompletedPhase 2/3

NCT04870333

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

COVID-19 (SARS-CoV2 virus) was declared a global pandemic by the WHO on 11th March 2020. Currently there are no drugs proven to prevent COVID-19 or to reduce th…

United Kingdom2,240 participantsStarted 2021-02-19Updated 2025-06-20

Infectious Complications Following HSCT

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

All recent trials (13 shown)

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

All recent trials (13 shown)

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation

Prophylactic Application of Donor-derived TCM After Allogeneic HSCT

Efficacy of Azithromycin to Prevent Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplan…

Diagnosis of Lung Complication After Allo-HSCT by Multiple Parameter System Through BAL

Hyperpolarized 129Xe MRI for the Assessment of BOS With Late Onset LONIPC

Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Periphera…